Format

Send to

Choose Destination
IDrugs. 2003 Apr;6(4):351-9.

Recent progress toward the clinical development of new anti-MRSA antibiotics.

Author information

1
University of South Florida, Department of Chemistry, 4202 East Fowler Avenue, Tampa, FL 33620-5205, USA. tlong@helios.acomp.usf.edu

Abstract

The escalation in drug resistance is well documented for methicillin-resistant Staphylococcus aureus (MRSA) and the urgency to discover new antibiotic treatments is more apparent with the growing incidences of vancomycin-intermediate and vancomycin-resistant S aureus. Much of the current research into finding new remedies focuses on chemical modification of existing antibiotics (ie, glycopeptides and cephalosporins) and developing synthetic molecules with novel mechanisms of action (ie, oxazolidinones and N-thiolated b-lactams). This review describes recent progress toward the clinical development of new drug therapies for MRSA.

PMID:
12789606
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center